Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.7%

6 terminated/withdrawn out of 352 trials

Success Rate

91.7%

+5.2% vs industry average

Late-Stage Pipeline

12%

41 trials in Phase 3/4

Results Transparency

6%

4 of 66 completed trials have results

Key Signals

65 recruiting4 with results4 withdrawn

Enrollment Performance

Analytics

N/A
91(46.2%)
Phase 2
50(25.4%)
Phase 3
23(11.7%)
Phase 4
18(9.1%)
Phase 1
13(6.6%)
Early Phase 1
2(1.0%)
197Total
N/A(91)
Phase 2(50)
Phase 3(23)
Phase 4(18)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (352)

Showing 20 of 352 trials
NCT06482645Not ApplicableRecruiting

Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer

Role: collaborator

NCT07635355Not Yet Recruiting

Real-World Data Linkage Research Platform

Role: lead

NCT05941377Not ApplicableCompleted

China Antihypertensive Trial for Intracranial Aneurysm

Role: collaborator

NCT07616583Not ApplicableRecruiting

Standardized Study Protocol of Percutaneous Vertebroplasty Based on Pedicle Nine-Grid Zoning Method

Role: lead

NCT07611266Recruiting

Prediction Model of Colorectal Adenoma Recurrence-Carcinogenesis Risk With TCM-WM Multimodal Feature Fusion

Role: lead

NCT07596290Phase 2Not Yet Recruiting

Yang et al. Anti-PD-1/CTLA-4 Dual Immunotherapy for LARC

Role: lead

NCT06855758Not ApplicableRecruiting

Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation

Role: lead

NCT07597395Phase 3Not Yet Recruiting

ATRA for Management of Primary ITP

Role: collaborator

NCT06788548Not ApplicableRecruiting

Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer（IDEAL Stage 2b）

Role: lead

NCT03385902Not ApplicableCompleted

Assessment of Dialysis Initiation by a Fuzzy Mathematics Equation

Role: collaborator

NCT07566559Recruiting

Rectal Cancer Neoadjuvant Therapy-Real World Study

Role: lead

NCT07541001Phase 2Active Not Recruiting

PRL3-Zumab in Patients With Advanced Solid Tumors

Role: collaborator

NCT07353684Phase 2Recruiting

Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer

Role: lead

NCT07393048Recruiting

Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer

Role: lead

NCT07541651Not Yet Recruiting

Study on Eye-Brain Cross-Organ Mapping and Systemic Disease Association Based on Multimodal Big Data

Role: lead

NCT07312864Phase 1Recruiting

Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome

Role: lead

NCT07265544Recruiting

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

Role: collaborator

NCT07089862Not ApplicableRecruiting

INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)

Role: collaborator

NCT07453862Phase 1Recruiting

Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety

Role: lead

NCT07450651Not Yet Recruiting

Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis

Role: lead